News

PharmiWeb1h

"Ozempic Makeovers" on the Rise: Dr. Meegan Gruber Addresses Post-Weight-Loss Skin Laxity With Awake Body Contouring

TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...

Lexaria Bioscience Corp.: Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study

DehydraTECH-semaglutide reduces overall side effects by 36.5% as compared to Rybelsus®DehydraTECH-semaglutide reduces gastrointestinal side effects by 43.5% as compared to Rybelsus®DehydraTECH-GLP-1 s ...

Gruber Plastic Surgery: "Ozempic Makeovers" on the Rise: Dr. Meegan Gruber Addresses Post-Weight-Loss Skin Laxity With Awake Body Contouring

TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...

Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...